Qualification opinion on ingestible sensor system for medication adherence as biomarker for measurin
Proteus® Digital Health™ Inc. (Proteus) has developed an ingestible event marker (IEM, also known as ingestible sensor (IS)), a platform technology that can be co-formulated with active pharmaceutical compounds into drug/device combinations, integrating measuring of medication adherence into oral pharmacotherapy.
The CHMP agrees in considering the use of the proteus technology (IS) as a qualified method for measuring adherence in clinical trials.
Click on this link for more information.
